Biochemical Studies of 14 kDa Phospholipases A2
14 kDa 磷脂酶 A2 的生化研究
基本信息
- 批准号:6849331
- 负责人:
- 金额:$ 33.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-02-11 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:X ray crystallographyactive sitescaveolinscell linecell membraneclinical researchelectron microscopyelectron spin resonance spectroscopyenzyme activityenzyme mechanismhuman tissueimmunocytochemistryin situ hybridizationinflammationmembrane lipidsphospholipase A2phospholipase Cphospholipase inhibitorpolymerase chain reactionprotein bindingprotein structure functionreceptor binding
项目摘要
DESCRIPTION: (provided by applicant) Phospholipases A2 (PLA2s) catalyze the
hydrolysis of the sn-2 ester of membrane phospholipids to produce a free fatty
acid and a lysophospholipid. There has been considerable interest in these
enzymes because of their role in the liberation of arachidonic acid from
mammalian cell membranes for the biosynthesis of the eicosanoid mediators of
inflammation (prostaglandins, leukotrienes, and others). There is also
considerable interest in these enzymes as a paradigm for understanding
interfacial enzymology (the action of enzymes at the lipid-water interface).
Many enzymes in cells operate on membranes. Mammalian cells contain two types
of PLA2s that are involved in arachidonic acid production. The secreted PLA2s
(sPLA2s) are 14-18 kDa, calcium-dependent enzymes that are secreted from a
large number of mammalian cells following stimulation with pro-inflammatory
mediators. Mammalian cells also contain an 87-kDA cytosolic PLA2 (cPLA2) that
translocates to the membrane in response to a rise in cytosolic calcium.
Recently we have cloned several new mouse and human sPLA2s. Thus, it is now
clear that the sPLA2s constitute a superfamily of proteins in mammals. We have
made significant progress toward the production of recombinant forms of the
full set of mouse and human sPLA2s. We will complete this process and also
study the interfacial kinetic and binding properties of these enzymes.
We are now faced with the task of determining the expression profile of these
sPLA2s in mammalian cells, and our studies will focus on cells from the airways
of normal and asthmatic patients. It is well established that eicosanoids play
a prominent role in causing many of the symptoms associated with asthma. It is
important to determine which PLA2s are involved in releasing arachidonic acid.
Such information will be useful in designing a new generation of therapeutics
for treatment of airway inflammatory disorders. Once we have identified the
PLA2s that are expressed in human airway cells, we will use PLA2-specific
antibodies and small molecular weight inhibitors to probe whether these enzymes
are involved in arachidonic acid release.
The mechanisms by which PLA2s act in mammalian cells to liberate arachidonic
acid are partially understood. Some sPLA2s act extracellularly on the plasma
membrane of cells, while others are internalized into punctate intracellular
membrane compartments. For the latter case, it is important to define this
membrane compartment in more detail and to determine where the enzyme acts to
release arachidonic acid. These studies will contribute to our fundamental
understanding of how mammalian cells initiate the eicosanoid cascade.
描述:(由申请人提供)磷脂酶A2(PLA 2s)催化
膜磷脂的sn-2酯的水解以产生游离脂肪
酸和溶血磷脂。对这些问题的兴趣很大,
酶,因为它们在花生四烯酸的释放中的作用,
哺乳动物细胞膜用于类花生酸介质的生物合成
炎症(白藜芦醇、白三烯等)。还有
相当大的兴趣,这些酶作为一个范例,了解
界面酶学(酶在脂-水界面的作用)。
细胞中的许多酶在膜上起作用。哺乳动物细胞包含两种类型
参与花生四烯酸生产的PLA 2。分泌的PLA 2
(sPLA 2)是14-18 kDa的钙依赖性酶,由细胞分泌,
大量哺乳动物细胞在用促炎剂刺激后
调解员哺乳动物细胞还含有87-kDA胞质PLA 2(cPLA 2),
响应胞质钙升高而转移到膜上。
最近,我们克隆了几个新的小鼠和人sPLA 2。因此,现在
很明显,sPLA 2在哺乳动物中构成了一个蛋白质超家族。我们有
在生产重组形式的
全套小鼠和人sPLA 2。我们将完成这一进程,
研究这些酶的界面动力学和结合特性。
我们现在面临的任务是确定这些基因的表达谱,
哺乳动物细胞中的sPLA 2,我们的研究将集中在气道细胞
正常人和哮喘患者的情况。众所周知,类二十烷酸起着
在引起许多与哮喘相关的症状方面起着重要作用。是
重要的是确定哪些PLA 2参与释放花生四烯酸。
这些信息将有助于设计新一代的治疗方法
用于治疗气道炎性疾病。一旦我们确定了
PLA 2在人气道细胞中表达,我们将使用PLA 2特异性
抗体和小分子量抑制剂来探测这些酶是否
参与花生四烯酸的释放
PLA 2在哺乳动物细胞中释放花生四烯酸的机制
酸是部分理解的。一些sPLA 2细胞外作用于血浆
细胞膜,而另一些则内化为点状细胞内
膜隔室对于后一种情况,定义这一点很重要
更详细地了解膜隔室,并确定酶在何处起作用,
释放花生四烯酸。这些研究将有助于我们的基本
了解哺乳动物细胞如何启动类花生酸级联反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael H Gelb其他文献
Therapeutic intervention based on protein prenylation and associated modifications
基于蛋白质异戊烯化及相关修饰的治疗干预
- DOI:
10.1038/nchembio818 - 发表时间:
2006-09-18 - 期刊:
- 影响因子:13.700
- 作者:
Michael H Gelb;Lucas Brunsveld;Christine A Hrycyna;Susan Michaelis;Fuyuhiko Tamanoi;Wesley C Van Voorhis;Herbert Waldmann - 通讯作者:
Herbert Waldmann
Michael H Gelb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael H Gelb', 18)}}的其他基金
Novel diagnostic biomarker reference standards for newborn screening of Mucopolysaccharidoses type I and II.
用于新生儿粘多糖病 I 型和 II 型筛查的新型诊断生物标志物参考标准。
- 批准号:
10757151 - 财政年份:2023
- 资助金额:
$ 33.39万 - 项目类别:
A tandem mass spectrometry diagnostic test for newborn screening of Tay-Sachs and Sandhoff diseases
用于新生儿泰萨克斯病和桑德霍夫病筛查的串联质谱诊断测试
- 批准号:
10484192 - 财政年份:2022
- 资助金额:
$ 33.39万 - 项目类别:
Conference on Drug Against Tropical Protozoan Parasites
热带原生动物寄生虫药物会议
- 批准号:
6439860 - 财政年份:2002
- 资助金额:
$ 33.39万 - 项目类别:
Biochemical Studies of 14 kDa Phospholipases A2
14 kDa 磷脂酶 A2 的生化研究
- 批准号:
6430660 - 财政年份:2002
- 资助金额:
$ 33.39万 - 项目类别:
Biochemical Studies of 14 kDa Phospholipases A2
14 kDa 磷脂酶 A2 的生化研究
- 批准号:
6621143 - 财政年份:2002
- 资助金额:
$ 33.39万 - 项目类别:
Biochemical Studies of 14 kDa Phospholipases A2
14 kDa 磷脂酶 A2 的生化研究
- 批准号:
7015023 - 财政年份:2002
- 资助金额:
$ 33.39万 - 项目类别:
Biochemical Studies of 14 kDa Phospholipases A2
14 kDa 磷脂酶 A2 的生化研究
- 批准号:
6703048 - 财政年份:2002
- 资助金额:
$ 33.39万 - 项目类别:
Multiplex Analysis of Inborn Errors of Metabolism
先天性代谢缺陷的多重分析
- 批准号:
9923620 - 财政年份:1999
- 资助金额:
$ 33.39万 - 项目类别:
MULTIPLEX ANALYSIS OF INBORN ERRORS OF METABOLISM
先天性代谢缺陷的多重分析
- 批准号:
6387033 - 财政年份:1999
- 资助金额:
$ 33.39万 - 项目类别:
Multiplex Analysis of Inborn Errors of Metabolism
先天性代谢缺陷的多重分析
- 批准号:
9277449 - 财政年份:1999
- 资助金额:
$ 33.39万 - 项目类别:
相似海外基金
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 33.39万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 33.39万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 33.39万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 33.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 33.39万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 33.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 33.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 33.39万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 33.39万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 33.39万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




